T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Copart
CPRT
$27.2B
| $6.67M | ﹤0.01% |
1,504,000
+51,200
| +4% | +$231K |
|
1427
O-I Glass
OI
$1.05B
| $6.62M | ﹤0.01% |
288,730
-90
| -0% | -$2.19K |
|
1428
IQVIA
IQV
$39.8B
| $6.51M | ﹤0.01% |
89,600
+3,400
| +4% | +$233K |
|
1429
Innoviva
INVA
$1.5B
| $6.41M | ﹤0.01% |
354,594
+16,930
| +5% | +$291K |
|
1430
Berkshire Hathaway Class A
BRK.A
$1.09T
| $6.35M | ﹤0.01% |
31
-5
| -14% | -$1.07M |
|
|
KDNY
1431
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $6.35M | ﹤0.01% |
+41,860
| New | +$6.91M |
|
|
ICON
1432
DELISTED
Iconix Brand Group, Inc.
ICON
| $6.32M | ﹤0.01% |
25,325
-2,830
| -10% | -$789K |
|
1433
First Solar
FSLR
$24B
| $6.29M | ﹤0.01% |
133,955
+1,100
| +0.8% | +$61.5K |
|
1434
ATI
ATI
$30.9B
| $6.26M | ﹤0.01% |
207,221
+6,110
| +3% | +$202K |
|
1435
Herc Holdings
HRI
$5.64B
| $6.23M | ﹤0.01% |
114,533
+463
| +0.4% | +$28.6K |
|
1436
Sabre
SABR
$892M
| $6.11M | ﹤0.01% |
+256,900
| New | +$6.47M |
|
|
PACW
1437
DELISTED
PacWest Bancorp
PACW
| $6.07M | ﹤0.01% |
129,885
-3,500
| -3% | -$162K |
|
|
CYBR
1438
DELISTED
CyberArk
CYBR
| $6.07M | ﹤0.01% |
96,593
+2,103
| +2% | +$135K |
|
|
GNBC
1439
DELISTED
Green Bancorp, Inc
GNBC
| $6.05M | ﹤0.01% |
394,152
+94,052
| +31% | +$1.26M |
|
1440
Cohu
COHU
$2.76B
| $5.96M | ﹤0.01% |
450,170
-856,177
| -66% | -$10.3M |
|
1441
Standex International
SXI
$3.97B
| $5.94M | ﹤0.01% |
74,300
+3,200
| +5% | +$260K |
|
|
TVTY
1442
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $5.9M | ﹤0.01% |
492,470
-39,410
| -7% | -$654K |
|
1443
Enerpac Tool Group
EPAC
$1.89B
| $5.79M | ﹤0.01% |
250,900
-46,800
| -16% | -$1.12M |
|
|
NAUH
1444
DELISTED
National American University Holdings, Inc.
NAUH
| $5.78M | ﹤0.01% |
1,984,743
+20,200
| +1% | +$63.8K |
|
|
MDSO
1445
DELISTED
Medidata Solutions, Inc.
MDSO
| $5.76M | ﹤0.01% |
106,061
-2,189,000
| -95% | -$118M |
|
1446
Hyster-Yale Materials Handling
HY
$617M
| $5.73M | ﹤0.01% |
82,694
+3,500
| +4% | +$255K |
|
|
INFO
1447
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $5.69M | ﹤0.01% |
222,500
+15,200
| +7% | +$401K |
|
|
ENTL
1448
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $5.69M | ﹤0.01% |
219,869
-12,343
| -5% | -$312K |
|
1449
lululemon athletica
LULU
$13.6B
| $5.68M | ﹤0.01% |
87,000
-5,000
| -5% | -$325K |
|
|
BAC.WS.A
1450
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $5.64M | ﹤0.01% |
914,325
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.